A detailed history of State Street Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 4,190,505 shares of IONS stock, worth $169 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,190,505
Previous 4,155,664 0.84%
Holding current value
$169 Million
Previous $180 Million 10.86%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $1.27 Million - $1.66 Million
34,841 Added 0.84%
4,190,505 $200 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $6.17 Million - $7.86 Million
146,867 Added 3.66%
4,155,664 $180 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $2.33 Million - $2.78 Million
53,768 Added 1.36%
4,008,797 $203 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $747,824 - $915,453
-19,424 Reduced 0.49%
3,955,029 $179 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $3.26 Million - $4.07 Million
-93,881 Reduced 2.31%
3,974,453 $163 Million
Q1 2023

May 15, 2023

SELL
$33.58 - $41.2 $5.05 Million - $6.2 Million
-150,395 Reduced 3.56%
4,068,334 $145 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $17 Million - $21.3 Million
457,774 Added 12.17%
4,218,729 $159 Million
Q3 2022

Nov 15, 2022

SELL
$36.54 - $48.66 $16.1 Million - $21.5 Million
-441,919 Reduced 10.51%
3,760,955 $166 Million
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $5.46 Million - $7.41 Million
172,228 Added 4.27%
4,202,874 $156 Million
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $3.71 Million - $4.6 Million
124,271 Added 3.18%
4,030,646 $149 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $9.86 Million - $13.5 Million
385,061 Added 10.94%
3,906,375 $119 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $9.74 Million - $11.8 Million
290,363 Added 8.99%
3,521,314 $118 Million
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $6.17 Million - $8.44 Million
-178,620 Reduced 5.24%
3,230,951 $129 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $21.4 Million - $32.1 Million
-503,757 Reduced 12.87%
3,409,571 $153 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $16.2 Million - $21.6 Million
358,434 Added 10.08%
3,913,328 $221 Million
Q3 2020

Nov 10, 2020

SELL
$47.45 - $62.95 $1.69 Million - $2.24 Million
-35,529 Reduced 0.99%
3,554,894 $169 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $14.2 Million - $18.5 Million
-302,471 Reduced 7.77%
3,590,423 $212 Million
Q1 2020

May 11, 2020

BUY
$41.6 - $63.4 $162 Million - $247 Million
3,892,894 New
3,892,894 $184 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.73B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.